Parivash Nourjah
Agency for Healthcare Research and Quality
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Parivash Nourjah.
European Journal of Preventive Cardiology | 2005
Stephen R. Benoit; Aaron B. Mendelsohn; Parivash Nourjah; Judy A. Staffa; David J. Graham
Background QT interval prolongation can lead to torsades de pointes, a potentially fatal arrhythmia. Although research exists on the relationship between QT prolongation and clinical outcome, few studies have described risk factors for prolonged QT interval in the general population. Methods The Third National Health and Nutrition Examination Survey (NHANES III) collected electrocardiogram interval data on 8561 subjects over 40 years of age and projected results to the US population. QT was corrected for heart rate using Fridericias formula. Logistic regression analyses were performed to identify factors independently associated with prolonged QTc interval, defined as being in the upper 5% of the population QTc interval distribution. Analyses were conducted separately for women and men as a result of differences in the QT distribution between the sexes and also because of potential effect modification. Analytical variables included age, race/ethnicity, electrolyte measurements, body mass index, the recent use of QT-prolonging drugs and past medical histories of stroke, thyroid disease, hypertension, diabetes and myocardial infarction. Results Age, female sex, hypocalcemia (men), hypokalemia (women), and a history of thyroid disease and myocardial infarction (men) were associated with a prolonged QTc interval. In addition, taking QT-prolonging medications in the past month was associated with more than a twofold increase in the odds of prolonged QTc interval in both men and women. Conclusions Healthcare practitioners should be aware that a prolonged QTc interval is a potential indicator of cardiovascular risk, and should exercise caution in prescribing potentially QT-prolonging medications to certain patients.
Pharmacoepidemiology and Drug Safety | 2011
Lisa J. Herrinton; Jeffrey R. Curtis; Lang Chen; Liyan Liu; Elizabeth Delzell; James D. Lewis; Daniel H. Solomon; Marie R. Griffin; Rita Ouellet-Hellstom; Timothy Beukelman; Carlos G. Grijalva; Kevin Haynes; Bindee Kuriya; Joyce Lii; Ed Mitchel; Nivedita M. Patkar; Jeremy A. Rassen; Kevin L. Winthrop; Parivash Nourjah; Kenneth G. Saag
Although biologic treatments have excellent efficacy for many autoimmune diseases, safety concerns persist. Understanding the absolute and comparative risks of adverse events in patient and disease subpopulations is critical for optimal prescribing of biologics.
Pharmacoepidemiology and Drug Safety | 2009
Mary Willy; Judith P. Kelly; Parivash Nourjah; David W. Kaufman; Daniel S. Budnitz; Judy A. Staffa
To estimate the rate of emergency department (ED) visits attributed to selected analgesic‐containing medications.
Journal of The American Pharmacists Association | 2008
Lauren Y. Lee; Cindy M. Kortepeter; Mary E. Willy; Parivash Nourjah
OBJECTIVES To gain insight on the knowledge, opinions, barriers, and practices of pharmacists regarding drug risk-minimization tools. DESIGN Descriptive, nonexperimental, cross-sectional survey. SETTING 20 states in the United States, fall 2004. PARTICIPANTS 2,052 randomly selected licensed pharmacists employed in a position requiring an active pharmacist license at the time of the survey and who responded to the survey. INTERVENTION Participants completed a four-page survey regarding their experience with different types of risk-minimization tools. MAIN OUTCOME MEASURE Univariate distributions for each question were analyzed. RESULTS 50% of survey recipients responded to the mailing; 88% of respondents had an active pharmacist license. Of respondents, 18% reported never having received a Dear Healthcare Professional letter and 29% stated that they were not familiar with Medication Guides. Patient package inserts were thought to be somewhat effective by 53% of respondents. Of pharmacists who dispensed a drug with programs for special stickers to be affixed on prescriptions to indicate that the labeled risk had been addressed by the prescriber, 41% reported receiving a prescription without a sticker; 45% dispensed the prescription when stickers were missing. Sixty percent of pharmacists stated that risk-minimization programs have a negative impact on the daily practice of pharmacy; nevertheless, many acknowledged that it was a necessary duty. CONCLUSION Pharmacists might benefit from additional training on risk-minimization strategies. The successful implementation and impact of risk-minimization programs on the practice of pharmacy should be carefully considered by drug manufacturers and regulators.
Clinical Chemistry | 2003
Diane K. Wysowski; Cynthia Kornegay; Parivash Nourjah; Anne Trontell
An association between low serum potassium and prolongation of the electrocardiographic QT interval and cardiac arrhythmia has been known for some time (1)(2)(3). High serum potassium has also been found to be independently associated with increased cardiovascular mortality (4). However, population distributions of serum potassium have not been published recently, and as a result, physicians may not appreciate the prevalence of abnormal concentrations in the population. Knowledge of the prevalence of abnormal serum potassium concentrations is important when prescribing diuretics or drugs that are arrhythmogenic in the presence of hypo- or hyperkalemia. This report describes the distribution by age and sex of serum potassium concentrations in the US population and provides data on the prevalence of abnormal concentrations. The National Health and Nutrition Examination Survey (NHANES) is a nationwide probability sample of the noninstitutionalized civilian population of the US. NHANES has been conducted on a periodic basis since the early 1970s. Baseline data collection usually includes a medical history, standardized medical examination, dietary assessment, laboratory tests, and anthropometric measurements. Serum potassium was measured in participants of the third survey (NHANES III), which was performed during the period 1988–1994. Frozen sera were collected and sent for analyses to the CDC. Potassium values were obtained only …
JAMA Internal Medicine | 2007
Parivash Nourjah; Lynette Swartz
Pharmacoepidemiology and Drug Safety | 2013
Eric S. Johnson; Barbara A. Bartman; Becky A. Briesacher; Neil S. Fleming; Tobias Gerhard; Cynthia Kornegay; Parivash Nourjah; Brian C. Sauer; Glen T. Schumock; Art Sedrakyan; Til Stürmer; Suzanne L. West; Sebastian Schneeweiss
Archives of Dermatology | 2005
Allen Brinker; Cynthia Kornegay; Parivash Nourjah
American Journal of Roentgenology | 2006
Diane K. Wysowski; Parivash Nourjah
Public Health Reports | 2004
Diane K. Wysowski; Parivash Nourjah